Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice
Connolly, P.; Wheat, J.; Schnizlein-Bick, C.; Durkin, M.; Kohler, S.; Smedema, M.; Goldberg, J.; Brizendine, E.; Loebenberg, D.
Antimicrobial Agents and ChemoTherapy 43(2): 322-328
1999
ISSN/ISBN: 0066-4804 PMID: 9925526 Accession: 003073894
A murine model of intratracheally induced Histoplasma capsulatum infection was used to evaluate Schering (SCH) 56592 for treatment of histoplasmosis. Minimum inhibitory concentrations (MICs) were determined for SCH 56592, amphotericin B and itraconazole by testing yeast-phase isolates from 20 patients by a macrobroth dilution method.
PDF emailed within 1 workday: $29.90
Related References
Connolly, P.; Wheat, J.; Schnizlein-Bick, C.; Durkin, M.; Kohler, S.; Smedema, M.; Goldberg, J.; Brizendine, E.; Loebenberg, D. 1999: Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice Antimicrobial Agents and Chemotherapy 43(2): 322-328Connolly, P.; Wheat, L.J.; Schnizlein-Bick, C.; Durkin, M.; Kohler, S.; Smedema, M.; Goldberg, J.; Brizendine, E.; Loebenberg, D. 2000: Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice Antimicrobial Agents and ChemoTherapy 44(10): 2604-2608
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In Vitro Activity of the Echinocandin Antifungal Agent Ly303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp Antimicrobial Agents and Chemotherapy 42(10): 2726-2730
Oakley, K.L.; Moore, C.B.; Denning, D.W. 1998: In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp Antimicrobial Agents and ChemoTherapy 42(10): 2726-2730
Symonds, W.T.; O' Connor, G.; Nix, D.E. 1993: Focus on itraconazole: a broad spectrum antifungal agent for treatment of blastomycosis and histoplasmosis Hospital Formulary 28(1): 23...33
Goldberg, J.; Connolly, P.; Schnizlein-Bick, C.; Durkin, M.; Kohler, S.; Smedema, M.; Brizendine, E.; Hector, R.; Wheat, J. 2000: Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model Antimicrobial Agents and ChemoTherapy 44(6): 1624-1629
Uchida, K.; Hosaka, J.; Aoki, K.; Yamaguchi, H. 1991: In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses Japanese Journal of Antibiotics 44(5): 571-579
Uchida, K.; Matsuzaka, A.; Aoki, K.; Yamaguchi, H. 1991: In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses Japanese Journal of Antibiotics 44(5): 562-570
Zuckerman, J.M.; Tunkel, A.R. 1994: Itraconazole: a new triazole antifungal agent Infection Control and Hospital Epidemiology 15(6): 397-410
Boon-Long, J.; Mekha, N.; Poonwan, N.; Kusum, M.; Mikami, Y.; Yazawa, K.; Konyama, K. 1996: In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine Mycoses 39(11-12): 453-456
Carrillo-Muñoz, A.J.; Quindós, G.; Tur, C.; Ruesga, M.T.; Miranda, Y.; del Valle, O.; Cossum, P.A.; Wallace, T.L. 1999: In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole Journal of Antimicrobial ChemoTherapy 44(3): 397-401
Rudramurthy, S.M.; Jatana, M.; Singh, R.; Chakrabarti, A. 2013: In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole Mycoses 56(1): 39-46
Uchida, K.; Yamaguchi, H.; Shibuya, K. 1991: The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections Japanese Journal of Antibiotics 44(5): 588-599
LeMonte, A.M.; Washum, K.E.; Smedema, M.L.; Schnizlein-Bick, C.; Kohler, S.M.; Wheat, L.J. 2000: Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis Journal of Infectious Diseases 182(2): 545-550
Moore, C.B.; Walls, C.M.; Denning, D.W. 2000: In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B Antimicrobial Agents and ChemoTherapy 44(2): 441-443
Bodily, K.; Perfect, J.R.; Procop, G.; Washington, M.K.; Affronti, J. 1996: Small intestinal histoplasmosis: successful treatment with itraconazole in an immunocompetent host Gastrointestinal Endoscopy 43(5): 518-521
Kobayashi, G.S.; Travis, S.J.; Medoff, G. 1990: Comparison of fluconazole with amphotericin B in treatment of histoplasmosis in normal and immunosuppressed mice Reviews of Infectious Diseases 12(Suppl): S291-S293
Wheat, L.J.; Cloud, G.; Johnson, P.C.; Connolly, P.; Goldman, M.; Le Monte, A.; Fuller, D.E.; Davis, T.E.; Hafner, R. 2001: Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole Antimicrobial Agents and ChemoTherapy 45(8): 2354-2357
Majdabadi, N.; Falahati, M.; Heidarie-Kohan, F.; Farahyar, S.; Rahimi-Moghaddam, P.; Ashrafi-Khozani, M.; Razavi, T.; Mohammadnejad, S. 2018: Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis Assay and Drug Development Technologies 16(3): 141-149
Nathwani, D.; Green, S.T.; McGuire, W.; Goldberg, D.J.; Kennedy, D.H. 1989: New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis Scandinavian Journal of Infectious Diseases 21(3): 355-356